Welcome to episode 40 of AI in Action, the podcast that breaks down the hype and explores the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.
Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and in Europe.
Today's guest is Angeli Moeller, Leader of the AI program at Bayer Pharmaceuticals. Angeli and her team are developing AI lighthouse use cases along the whole Pharma value chain from Research & Development to Product Supply to Marketing & Sales. Bayer is eager to harness AI to detect diseases at an earlier stage, to provide more individualized treatments and to develop new medicines much more quickly and efficiently.
Angeli is also the Executive Officer and co-founder at the Alliance for Artificial Intelligence in Healthcare. AAIH is a global advocacy organization whose intent is to enable advancement and use of artificial intelligence in healthcare. AAIH believes that patients’ lives will be improved through investment, innovation and the thoughtful and responsible application of AI in the discovery and development of new therapies.
The goal at Bayer Pharmaceuticals
How AI is transforming patient treatment care
Challenging projects she has worked on
Her work with the Alliance for AI in Healthcare
Educating the public in Artificial Intelligence
How AI will continue to transform the healthcare sector
If you would like to find out more about Angeli and her work, check out www.bayer.com/en/pharmaceuticals-division and www.theaaih.org. You can also connect with Angeli on Linkedin and Twitter @angeli_moeller.
What did you make of Angeli's podcast? Where do you see the future of Artificial Intelligence and Data Science in the healthcare sector heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.
If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.